Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 24, 2024 4:31 PM 2 min read

Chipotle Mexican Grill Q2 Earnings: Revenue Beat, EPS Beat, Comps Up 11% On 'Stronger Demand Trends' And More

by Adam Eckert Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

Chipotle Mexican Grill Inc (NYSE:CMG) reported second-quarter financial results after the market close on Wednesday. Here’s a look at the key metrics from the quarter.

Q2 Earnings: Chipotle said second-quarter revenue increased 18.2% year-over-year to $2.97 billion, beating the consensus estimate of $2.94 billion. The fast-casual restaurant chain company reported adjusted earnings of 34 cents per share, beating analyst estimates of 32 cents per share.

Chipotle has now met or exceeded analyst estimates on the top and bottom lines in four straight quarters, according to data from Benzinga Pro.

Comparable restaurant sales increased 11.1% year-over-year driven by over 8% transaction growth as margins expanded. Digital sales represented 35.3% of food and beverage revenue. Operating margin was 19.7% in the second quarter, up from 17.2% year-over-year. 

Chipotle said it opened 52 new restaurants in the quarter, and 46 of those locations included a Chipotlane. The company also repurchased $151.4 million of its stock during the second quarter and said it has $647.7 million remaining under its share repurchase authorization.

“The second quarter was outstanding as successful brand marketing, including the return of Chicken Al Pastor, drove strong demand to our restaurants. Our focus and training around throughput paid off as we were able to meet the stronger demand trends with terrific service and speed driving over 8% transaction growth in the quarter,” said Brian Niccol, chairman and CEO of Chipotle.

Outlook: Chipotle reiterated expectations for full-year 2024 comparable restaurant sales growth in the mid to high single-digit range. The company said it still anticipates opening between 285 and 315 new restaurants in 2024 with over 80% including a Chipotlane.

Management will hold a conference call to discuss these results at 4:30 p.m. E.T.

See Also: US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What’s Driving Markets Wednesday?

CMG Price Action: Chipotle shares were up 10.89% after hours at $57.42 at the time of publication, according to Benzinga Pro.

Photo: courtesy of Chipotle.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsRestaurantsAfter-Hours CenterMoverswhy it's moving
CMG Logo
CMGChipotle Mexican Grill Inc
$32.610.15%
Overview
CMG Logo
CMGChipotle Mexican Grill Inc
$32.610.15%
Overview
Comments
Loading...